Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interventions for toxic epidermal necrolysis.

S Majumdar1, M Mockenhaupt, J- Roujeau

  • 116 Ariel Close, Basford, Nottingham, UK, NG6 0EH. sammajumdar@hotmail.com

The Cochrane Database of Systematic Reviews
|January 10, 2003
PubMed
Summary

Thalidomide treatment for toxic epidermal necrolysis (TEN) significantly increased mortality compared to placebo. Current evidence for TEN treatments, including steroids and immunoglobulins, is lacking, necessitating further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-Up.

Journal of investigational allergology & clinical immunology·2025
Same author

Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Epidemiology of cutaneous adverse drug reactions.

Allergologie select·2018
Same author

[Acute life-threatening drug reactions of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

[Severe skin reactions due to new medications].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

Is neutrophilic desquamative erythroderma a form of acute generalized exanthematous pustulosis?

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Area of Science:

  • Dermatology
  • Clinical Pharmacology
  • Evidence-Based Medicine

Background:

  • Toxic epidermal necrolysis (TEN) is a severe, rare drug reaction causing extensive skin loss.
  • It is associated with high morbidity and mortality.
  • Effective treatment strategies for TEN remain unclear.

Purpose of the Study:

  • To systematically assess all interventions for treating toxic epidermal necrolysis (TEN).

Main Methods:

  • Searched multiple databases including Cochrane, MEDLINE, EMBASE, DARE, and CINAHL up to December 2001.
  • Included randomized controlled trials (RCTs) of therapeutic and supportive interventions for clinically diagnosed TEN.
  • Study selection and quality assessment were performed by two independent reviewers.

Related Experiment Videos

Main Results:

  • Only one RCT was identified, comparing thalidomide to placebo in 22 patients.
  • The thalidomide group (12 patients) had 83% mortality versus 30% in the placebo group (10 patients).
  • No RCTs were found for commonly used treatments like systemic steroids, cyclosporin A, or intravenous immunoglobulins.

Conclusions:

  • Thalidomide treatment for TEN is ineffective and increases mortality.
  • Reliable evidence for current TEN treatments is absent, with typical mortality rates around 30%.
  • Further multi-center RCTs are crucial to evaluate treatments like high-dose steroids and IVIg for TEN.